Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Outstanding Shares Outstanding Shares Repurchased

Medifast (MED) Shares Issued (2016 - 2024)

Medifast's Shares Issued history spans 9 years, with the latest figure at $36000.0 for Q1 2024.

For Q1 2024, Shares Issued fell 65.71% year-over-year to $36000.0; the TTM value through Dec 2024 reached $36000.0, down 80.85%, while the annual FY2024 figure was $36000.0, 80.85% down from the prior year.
Shares Issued reached $36000.0 in Q1 2024 per MED's latest filing, down from $83000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $500000.0 in Q1 2021 to a low of -$11000.0 in Q4 2021.
Average Shares Issued over 4 years is $152666.7, with a median of $111000.0 recorded in 2021.
Peak YoY movement for Shares Issued: surged 728.57% in 2020, then tumbled 106.25% in 2021.
A 4-year view of Shares Issued shows it stood at $176000.0 in 2020, then crashed by 106.25% to -$11000.0 in 2021, then surged by 854.55% to $83000.0 in 2023, then tumbled by 56.63% to $36000.0 in 2024.
Per Business Quant, the three most recent readings for MED's Shares Issued are $36000.0 (Q1 2024), $83000.0 (Q4 2023), and $105000.0 (Q1 2023).